RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cesca Therapeutics adds Mark Bagnall to board

Cesca TherapeuticsCesca Therapeutics, a regenerative medicine company, announced that Mark Bagnall has been appointed to the board of directors from July 1, 2016.
Article continues below

READ MORE Cesca Therapeutics appoints Xiaochun Xu to board

Mr. Bagnall has more than 20 years of experience in senior management positions in both public and private biotechnology companies. He is the Co-Founder of Naia Pharmaceuticals where he currently serves as Director, Chief Financial Officer and Chief Operating Officer.

Mr. Bagnall serves as Chairman of the Board of XCR Diagnostics and as a director on the Board of Directors of Ativa Medical.

Prior to founding Naia, he served as President, Chief Executive Officer and a member of the Board of Directors of GenturaDx until its sale to Luminex Corporation in 2012. He has also served as the Executive Vice president and member of the Board of Directors of ADVENTRX Pharmaceuticals.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy